The Manitowoc Company, Inc.
NYSE:MTWAgricultural - Machinery
+$0.58 today
- Market cap
- $801.94M
- Beta
- 1.75
- P/E (TTM)
- 63.2
- EPS (TTM)
- $0.21
Volume 0.28M
Average 0.23M
MTW Revenue
Total income from selling goods and services before any costs are deducted; the top line of the income statement.
The Manitowoc Company, Inc.NYSE: MTW
Revenue · Q1 FY2026 · quarter ended Mar 2026
Revenue grows in line with its trailing trend
Q1 FY2026 revenue of $494.6M rose 5.0% year over year, in line with the +5.1% change in trailing-twelve-month revenue. Sequentially, it fell 27.0% from the prior quarter. Over 3 fiscal years it compounded at +3.3% a year.
Context
- Revenue increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether revenue reaches the consensus estimate from 1 analysts of $2.38B (+6.4%) for the fiscal year ending Dec 2026, a step up from the +2.9% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $494.6M-27.0% QoQ
- Last fiscal yearDec 2025
- $2.24B+2.9% YoY
- LTMMar 2026
- $2.26B+5.1% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +5.0% | +4.5% | -0.5 pp |
| 1 year | +2.9% | +6.4% | +3.5 pp |
| 3-year CAGR | +3.3% | +5.1% | +1.8 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Revenue history
USD · from the income statement
- Latest · FY2025
- 2.24B USD
- Year-over-year change
- +2.9%
- 4-year CAGR
- +6.8%
| Period | Period end | Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.24B | +2.9% |
| FY2024 | 2024-12-31 | 2.18B | -2.2% |
| FY2023 | 2023-12-31 | 2.23B | +9.6% |
| FY2022 | 2022-12-31 | 2.03B | +18.2% |
| FY2021 | 2021-12-31 | 1.72B | — |
Revenue vs competitors
How MTW compares with its peers on the latest reported figures
- MTW's LTM Mar 2026 revenue of $2.26B is the 2nd highest of the 10 companies compared; the peer median is $668.48M.
- Its year-over-year change of +5.1% is the 2nd highest of 10, against a peer median of -4.5%.
- Over three fiscal years its annual growth of +3.3% compares with a peer median of -1.2%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | $3.16B | -12.1% | -10.9% | |
| LTM Mar 2026 | $2.26B | +5.1% | +3.3% | |
| LTM Mar 2026 | $1.61B | -1.8% | +2.3% | |
| LTM Mar 2026 | $1.55B | -4.5% | -7.8% | |
| LTM Mar 2026 | $1.47B | -19.2% | -14.9% | |
| LTM Mar 2026 | $668.48M | +1.5% | -1.2% | |
| LTM Mar 2026 | $555.69M | -0.0% | +0.4% | |
| LTM Mar 2026 | $372.42M | +14.2% | +10.7% | |
| LTM Mar 2026 | $371.5M | -7.0% | -3.2% | |
SBCSBC Medical Group Holdings Incorporated | LTM Mar 2026 | $169.34M | -14.4% | -0.1% |
| Peer median (excluding MTW) | $668.48M | -4.5% | -1.2% | |
Competitors are the stored peer set for MTW. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.72B | 2.03B | 2.23B | 2.18B | 2.24B |
| Cost of Revenue | 1.41B | 1.67B | 1.8B | 1.8B | 1.84B |
| Gross Profit | 307.2M | 364.5M | 425.2M | 375M | 404.7M |
| Gross Margin | 17.9% | 17.9% | 19.1% | 17.2% | 18.1% |
| Research & Development | 0 | 0 | 35.3M | 0 | 0 |
| Selling, General & Admin | 258.5M | 281M | 334.3M | 318.6M | 342.9M |
| Operating Expenses | 260.7M | 457.5M | 332.8M | 323.2M | 346M |
| Depreciation & Amortization | 46.9M | 63.7M | 59.8M | 62.9M | 63M |
| EBITDA | 92.9M | (24.9M) | 139.2M | 112.9M | 113.1M |
| EBITDA Margin | 5.4% | -1.2% | 6.2% | 5.2% | 5.0% |
| Operating Income | 46.5M | (93M) | 92.4M | 51.8M | 58.7M |
| Operating Margin | 2.7% | -4.6% | 4.1% | 2.4% | 2.6% |
| Interest Income | 0 | 0 | 0 | 0 | 800K |
| Interest Expense | 28.9M | 31.6M | 35.2M | 39.7M | 37.7M |
| Other Income / Expenses | (29.4M) | (27.2M) | (48.2M) | (40.1M) | (46.3M) |
| Income Before Tax | 17.1M | (120.2M) | 44.2M | 11.7M | 12.4M |
| Pre-Tax Margin | 1.0% | -5.9% | 2.0% | 0.5% | 0.6% |
| Income Tax Expense | 6.1M | 3.4M | 5M | (44.1M) | 5.2M |
| Net Income | 11M | (123.6M) | 39.2M | 55.8M | 7.2M |
| Net Margin | 0.6% | -6.1% | 1.8% | 2.6% | 0.3% |
| EPS (Basic) | 0.32 | (3.51) | 1.12 | 1.58 | 0.20 |
| EPS (Diluted) | 0.31 | (3.51) | 1.09 | 1.56 | 0.20 |
| Weighted Avg Shares | 34.9M | 35.18M | 35.09M | 35.22M | 35.42M |
| Weighted Avg Shares (Diluted) | 35.45M | 35.18M | 35.96M | 35.71M | 36.09M |
The Manitowoc Company, Inc.
NYSE:MTW
Intrinsic Alpha fair value
Locked
Current Price
$22.21
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.